Seifert R, Jamieson J, Gardner R
Drug Intell Clin Pharm. 1983 Jun;17(6):470-3. doi: 10.1177/106002808301700618.
The Medicare Utilization Review Committee conducted a survey to determine the use of drugs with anticholinergic effects in confused elderly nursing home patients. Twenty-nine patients (34.5 percent) were receiving anticholinergic drugs, predominantly from the antidepressant and antipsychotic class. Thioridazine (Mellaril) was the most frequently used antipsychotic. No patients received higher than the equivalent recommended daily dose of atropine when calculated in terms of relative anticholinergic potency. No statistically significant correlation could be found between the presence of confusion and the amount of anticholinergics administered. Confusion and cognitive deterioration frequently are encountered when caring for aged patients. Clinical experience and recent studies suggest that anticholinergics may increase the risk of or exacerbate existing confusion, and this possible effect of anticholinergic activity should be considered when prescribing for elderly patients.
医疗保险利用审查委员会进行了一项调查,以确定患有认知障碍的老年疗养院患者使用具有抗胆碱能作用药物的情况。29名患者(34.5%)正在接受抗胆碱能药物治疗,主要来自抗抑郁药和抗精神病药物类别。硫利达嗪(美立廉)是最常用的抗精神病药物。按照相对抗胆碱能效力计算,没有患者接受高于等效推荐日剂量的阿托品。在认知障碍的存在与给予的抗胆碱能药物量之间未发现统计学上的显著相关性。在照顾老年患者时,经常会遇到认知障碍和认知能力下降的情况。临床经验和近期研究表明,抗胆碱能药物可能会增加出现认知障碍的风险或加重现有的认知障碍,在为老年患者开处方时应考虑抗胆碱能活性的这种可能影响。